A detailed history of Larson Financial Group LLC transactions in Incyte Corp stock. As of the latest transaction made, Larson Financial Group LLC holds 237 shares of INCY stock, worth $17,568. This represents 0.0% of its overall portfolio holdings.

Number of Shares
237
Previous 217 9.22%
Holding current value
$17,568
Previous $14,000 14.29%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 07, 2025

BUY
$65.08 - $83.38 $1,301 - $1,667
20 Added 9.22%
237 $16,000
Q3 2024

Nov 12, 2024

BUY
$57.33 - $68.61 $11,867 - $14,202
207 Added 2070.0%
217 $14,000
Q2 2024

Aug 02, 2024

SELL
$51.18 - $63.75 $21,597 - $26,902
-422 Reduced 97.69%
10 $0
Q4 2023

Feb 01, 2024

BUY
$52.16 - $64.19 $22,011 - $27,088
422 Added 4220.0%
432 $27,000
Q1 2022

May 05, 2022

BUY
$66.02 - $79.71 $660 - $797
10 New
10 $1,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16.5B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Larson Financial Group LLC Portfolio

Follow Larson Financial Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Larson Financial Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Larson Financial Group LLC with notifications on news.